Immunovia AB (publ) (IMMNOV.ST)
SEK 0.66
(1.23%)
SEK 0.66
(1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -147.05 Million | -175.58 Million | -152.64 Million | -120.7 Million | -91.95 Million | -84.11 Million |
| Net Income | -296.46 Million | -191.15 Million | -166.62 Million | -134.34 Million | -114.24 Million | -87.7 Million |
| Depreciation & Amortization | 141.71 Million | 24.91 Million | 19.06 Million | 9.76 Million | 8.44 Million | 2.77 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 7.13 Million | -7.15 Million | -5.33 Million | 4.53 Million | 14.88 Million | 605.23 Thousand |
| Other non-cash items | 13.52 Million | -2.19 Million | 255 Thousand | -656 Thousand | -1.03 Million | 214.98 Thousand |
| Investing Cash Flow | 3.19 Million | -1.62 Million | -23.82 Million | -46.95 Million | -36.6 Million | -37.28 Million |
| Investments in PPE | -1.06 Million | -1.62 Million | -24.18 Million | -47.49 Million | -36.6 Million | -37.28 Million |
| Acquisitions | 1.32 Million | - | 358 Thousand | 537 Thousand | - | - |
| Investment purchases | - | - | - | - | - | -2009.00 |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2.92 Million | -368 Thousand | -20.72 Million | -42.96 Million | -30.56 Million | -28.23 Million |
| Financing Cash Flow | 114.74 Million | -5.1 Million | -5.26 Million | 373.58 Million | 5.75 Million | 315.07 Million |
| Debt repayment | -6.5 Million | -5.74 Million | -5.7 Million | -4.93 Million | -5.11 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 121.24 Million | 639 Thousand | 440 Thousand | 378.51 Million | 10.58 Million | 312.28 Million |
| Other Financing Activities | 121.24 Million | -5.1 Million | -5.26 Million | 373.58 Million | 291 Thousand | 2.79 Million |
| Accounts receivables | 4.73 Million | 298 Thousand | -1.09 Million | -579 Thousand | 6.62 Million | -840.3 Thousand |
| Accounts payables | - | -298 Thousand | 1.09 Million | 5.11 Million | 8.26 Million | 1.44 Million |
| Inventory | 1.99 Million | 438 Thousand | -2.03 Million | -5.11 Million | - | - |
| Other working capital | 409 Thousand | -7.59 Million | -3.3 Million | 5.11 Million | 1.00 | 1.44 Million |
| Cash at beginning of period | 106.04 Million | 287.4 Million | 468.46 Million | 263.34 Million | 386.13 Million | 192.42 Million |
| Cash at end of period | 76.78 Million | 106.04 Million | 287.4 Million | 468.46 Million | 263.34 Million | 386.13 Million |
| Capital Expenditure | -1.06 Million | -1.62 Million | -24.18 Million | -47.49 Million | -36.6 Million | -37.28 Million |
| Effect of forex changes on cash | -136 Thousand | 948 Thousand | 687 Thousand | -801 Thousand | 6000.00 | 30.8 Thousand |
| Net cash flow / Change in cash | -29.25 Million | -181.36 Million | -181.05 Million | 205.11 Million | -122.79 Million | 193.71 Million |
| Free Cash Flow | -148.11 Million | -177.2 Million | -176.83 Million | -168.19 Million | -128.55 Million | -121.39 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -23.9 Million | -24.15 Million | -23.4 Million | -296.46 Million | -38.88 Million | -185.08 Million |
| Depreciation & Amortization | 1.59 Million | 2.98 Million | 2.43 Million | 141.71 Million | 2.49 Million | 130.71 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4.42 Million | -3.63 Million | -7.34 Million | 7.13 Million | 143 Thousand | 10.65 Million |
| Other non-cash items | 1.71 Million | -17.84 Million | 25.43 Million | 13.52 Million | 678 Thousand | 416 Thousand |
| Investing Cash Flow | - | - | 711 Thousand | 3.19 Million | 39 Thousand | -1.04 Million |
| Investments in PPE | - | - | - | -1.06 Million | - | -1.06 Million |
| Acquisitions | - | - | -2.21 Million | 1.32 Million | 39 Thousand | 15 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 711 Thousand | 2.92 Million | 39 Thousand | -1.04 Million |
| Financing Cash Flow | 12.35 Million | -1.53 Million | -1.64 Million | 114.74 Million | -1.66 Million | 119.61 Million |
| Debt repayment | -2.14 Million | -1.53 Million | -1.64 Million | -6.5 Million | -1.66 Million | -1.62 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 14.5 Million | - | - | 121.24 Million | - | 121.24 Million |
| Other Financing Activities | 14.5 Million | - | -1.64 Million | 121.24 Million | -1.66 Million | 119.61 Million |
| Accounts receivables | -1.24 Million | -603 Thousand | 3.02 Million | 4.73 Million | 793 Thousand | 512 Thousand |
| Accounts payables | - | - | - | - | -793 Thousand | -512 Thousand |
| Inventory | - | - | -41 Thousand | 1.99 Million | 16 Thousand | 2.35 Million |
| Other working capital | -3.17 Million | -3.02 Million | -10.32 Million | 409 Thousand | 127 Thousand | 8.29 Million |
| Cash at beginning of period | 51.17 Million | 76.78 Million | 106.67 Million | 106.04 Million | 143.87 Million | 68.23 Million |
| Cash at end of period | 36.75 Million | 51.17 Million | 76.78 Million | 76.78 Million | 106.67 Million | 143.87 Million |
| Capital Expenditure | - | - | - | -1.06 Million | - | -1.06 Million |
| Effect of forex changes on cash | -66 Thousand | 347 Thousand | -469 Thousand | -136 Thousand | -8000.00 | 369 Thousand |
| Net cash flow / Change in cash | -14.42 Million | -25.61 Million | -29.88 Million | -29.25 Million | -37.2 Million | 75.64 Million |
| Free Cash Flow | -26.7 Million | -24.42 Million | -28.48 Million | -148.11 Million | -35.56 Million | -44.35 Million |
8111
0HYA
INNOVTEC
GNC
3535
0HFR